share_log

Insider Sale: CFO of $GNE (GNE) Sells 7,300 Shares

Quiver Quantitative ·  Nov 22, 2024 22:30

AVI GOLDIN, the CFO of $GNE ($GNE), sold 7,300 shares of the company on 11-20-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 5.4% of their shares. Following this trade, they now own 127,699 shares of $GNE stock.

$GNE Insider Trading Activity

$GNE insiders have traded $GNE stock on the open market 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales.

Here's a breakdown of recent trading of $GNE stock by insiders over the last 6 months:

  • AVI GOLDIN (CFO) has traded it 3 times. They made 0 purchases and 3 sales, selling 9,600 shares.
  • JAMES A COURTER sold 3,675 shares.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$GNE Hedge Fund Activity

We have seen 47 institutional investors add shares of $GNE stock to their portfolio, and 69 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

  • DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN removed 124,501 shares (-100.0%) from their portfolio in Q2 2024
  • AMERICANA PARTNERS, LLC added 87,625 shares (+313.8%) to their portfolio in Q3 2024
  • BRANDYWINE GLOBAL INVESTMENT MANAGEMENT, LLC removed 85,885 shares (-100.0%) from their portfolio in Q3 2024
  • J. GOLDMAN & CO LP removed 83,333 shares (-12.4%) from their portfolio in Q3 2024
  • JANNEY MONTGOMERY SCOTT LLC removed 67,420 shares (-100.0%) from their portfolio in Q3 2024
  • BLACKROCK, INC. added 64,089 shares (+5.6%) to their portfolio in Q3 2024
  • FIRST TRUST ADVISORS LP removed 60,315 shares (-100.0%) from their portfolio in Q3 2024

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.


This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment